LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 1133

Search options

  1. Book ; Online ; E-Book: The Everglades Handbook

    Lodge, Thomas E. / Davis, Stephen E.

    Understanding the Ecosystem

    2024  

    Abstract: This fifth edition is packed with scientific information about the ecosystem of the Everglades - taking into account how drastically the Everglades has changed. The book covers disciplines ranging from ecology, geology, climatology, hydrology, ... ...

    Author's details Thomas E. Lodge and Stephen E. Davis III
    Abstract "This fifth edition is packed with scientific information about the ecosystem of the Everglades - taking into account how drastically the Everglades has changed. The book covers disciplines ranging from ecology, geology, climatology, hydrology, anthropology to conservation biology. The updated edition presents expanded treatment of subjects where our knowledge of the Everglades and its restoration has greatly improved. This includes a new chapter 'A Chemistry Primer for the Everglades' and discussion of the politics of Everglades Restoration. This text is essential reading for anybody trying to understand the challenges we face in restoring this unique ecosystem"--
    Keywords Ecosystem management ; Swamp animals ; Swamp plants ; Everglades (Fla.)
    Subject code 333.95
    Language English
    Size 1 online resource (521 pages)
    Edition Fifth edition.
    Publisher CRC Press
    Publishing place Boca Raton, FL
    Document type Book ; Online ; E-Book
    Remark Zugriff für angemeldete ZB MED-Nutzerinnen und -Nutzer
    ISBN 1-00-326668-1 ; 1-003-26668-1 ; 1-000-92246-4 ; 1-000-92248-0 ; 9781032210926 ; 978-1-00-326668-6 ; 978-1-003-26668-6 ; 978-1-000-92246-2 ; 978-1-000-92248-6 ; 1032210923
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    Kategorien

  2. Article ; Online: Is Law Enforcement Support the Missing Key to Thriving Syringe Service Programs in US Rural Areas?

    Davis, Stephen M / Kristjansson, Alfgeir L

    American journal of public health

    2024  Volume 114, Issue 5, Page(s) 458–460

    MeSH term(s) Humans ; Law Enforcement ; Substance Abuse, Intravenous ; Needle-Exchange Programs ; Police
    Language English
    Publishing date 2024-04-11
    Publishing country United States
    Document type Journal Article
    ZDB-ID 121100-6
    ISSN 1541-0048 ; 0090-0036 ; 0002-9572
    ISSN (online) 1541-0048
    ISSN 0090-0036 ; 0002-9572
    DOI 10.2105/AJPH.2024.307647
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Book: Magnetic resonance imaging in stroke

    Davis, Stephen M.

    2003  

    Author's details ed. by Stephen Davis
    Keywords Cerebrovascular Accident / diagnosis ; Magnetic Resonance Imaging / methods ; Schlaganfall ; Kernspintomografie
    Subject Kernspintomographie ; NMR-Tomographie ; Magnetische Kernresonanztomographie ; MR-Tomographie ; Kernspinresonanztomographie ; MRI ; Magnetic resonance imaging ; IRM ; Magnetresonanztomographie ; Magnetresonanztomografie ; MRT ; NMR-Tomografie ; Nukleare Kernspintomographie ; MR-Bildgebung ; Apoplektischer Insult ; Apoplexia cerebri ; Apoplexie ; Gehirnschlag ; Hirnschlag ; Zerebrovaskulärer Insult ; ZVI ; Ischämischer Insult ; Stroke
    Language English
    Size XIV, 266 S. : Ill., graph. Darst.
    Publisher Cambridge Univ. Press
    Publishing place Cambridge
    Publishing country Great Britain
    Document type Book
    HBZ-ID HT013644706
    ISBN 0-521-80683-6 ; 978-0-521-80683-1
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  4. Article ; Online: How close are we to personalized pharmacotherapies and innovative technology for type 1 diabetes management?

    Munir, Kashif M / Davis, Stephen N

    Expert opinion on pharmacotherapy

    2023  Volume 24, Issue 15, Page(s) 1661–1663

    MeSH term(s) Humans ; Diabetes Mellitus, Type 1/drug therapy ; Hypoglycemic Agents/therapeutic use ; Blood Glucose ; Technology ; Insulin/therapeutic use
    Chemical Substances Hypoglycemic Agents ; Blood Glucose ; Insulin
    Language English
    Publishing date 2023-08-03
    Publishing country England
    Document type Editorial
    ZDB-ID 2001535-5
    ISSN 1744-7666 ; 1465-6566
    ISSN (online) 1744-7666
    ISSN 1465-6566
    DOI 10.1080/14656566.2023.2241354
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Book: Interventional therapy in acute stroke

    Davis, Stephen M.

    1998  

    Author's details Stephen M. Davis
    Keywords Cerebrovascular Disorders / therapy
    Language English
    Size VIII, 274 S. : zahlr. Ill.
    Publisher Blackwell Science
    Publishing place Malden, Mass. u.a.
    Publishing country United States
    Document type Book
    HBZ-ID HT008403197
    ISBN 0-86542-377-6 ; 978-0-86542-377-0
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  6. Article ; Online: Formation of polycyclic aromatic hydrocarbons and regulated emissions from biodiesel and n-butanol blends containing water.

    Yilmaz, Nadir / Davis, Stephen M

    Journal of hazardous materials

    2022  Volume 437, Page(s) 129360

    Abstract: To increase the use of biofuels in diesel engines and reduce harmful emissions emitted from diesel fuel, biodiesel and higher alcohols are fuel sources at the forefront of research. The aim of this study is to understand the effect of water-containing n- ... ...

    Abstract To increase the use of biofuels in diesel engines and reduce harmful emissions emitted from diesel fuel, biodiesel and higher alcohols are fuel sources at the forefront of research. The aim of this study is to understand the effect of water-containing n-butanol-biodiesel blends on regulated emissions, emphasizing nitrogen oxides (NO
    MeSH term(s) 1-Butanol ; Biofuels/analysis ; Butanols ; Gasoline/analysis ; Polycyclic Aromatic Hydrocarbons/analysis ; Vehicle Emissions/analysis ; Water/chemistry
    Chemical Substances Biofuels ; Butanols ; Gasoline ; Polycyclic Aromatic Hydrocarbons ; Vehicle Emissions ; Water (059QF0KO0R) ; 1-Butanol (8PJ61P6TS3)
    Language English
    Publishing date 2022-06-11
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1491302-1
    ISSN 1873-3336 ; 0304-3894
    ISSN (online) 1873-3336
    ISSN 0304-3894
    DOI 10.1016/j.jhazmat.2022.129360
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: The role of Recent Pharmacotherapeutic Options on the Management of Treatment Resistant Type 2 Diabetes.

    Kroopnick, Jeffrey M / Davis, Stephen N

    Expert opinion on pharmacotherapy

    2022  Volume 23, Issue 11, Page(s) 1259–1271

    Abstract: Introduction: Type 2 diabetes mellitus is a complex progressive disease leading to chronic hyperglycemia due to insulin resistance and pancreatic beta-cell failure. Intensification of treatment regimens is often necessary due to the overall decline in ... ...

    Abstract Introduction: Type 2 diabetes mellitus is a complex progressive disease leading to chronic hyperglycemia due to insulin resistance and pancreatic beta-cell failure. Intensification of treatment regimens is often necessary due to the overall decline in insulin secretion. Unfortunately, many patients are unable to achieve optimal glycemic control despite the standard of care and thus may be classified as 'treatment resistant'.
    Areas covered: Newer pharmacotherapeutic agents, either injectable or oral, such as Glucagon-like-peptide-1 receptor agonists (GLP-1RA) and Sodium-glucose Cotransporter-2 (SGLT2) inhibitors are, herein, described. These agents can be used as single agents or fixed combinations that reduce glycemia while lessening the risk for hypoglycemia and renal and cardiovascular diseases.
    Expert opinion: If individualized target HbA1c is not obtained despite diet, lifestyle, and metformin therapy, then additional oral and injectable therapies should be considered. This may include newer agents such as GLP-1RA and SGLT2 inhibitors alone or in combination that provide renal protection and reduce cardiovascular and hypoglycemic risks. These newer agents have substantial potential for lowering HbA1c through differing but complementary mechanisms. Use of new insulin analogs with GLP-1RA preparations either alone or in fixed-ratio combinations, such as glargine/lixisenatide and degludec/liraglutide, can also reduce the multiple drug adherence burden while improving glycemic control.
    MeSH term(s) Blood Glucose ; Diabetes Mellitus, Type 2/drug therapy ; Glucagon-Like Peptide-1 Receptor/agonists ; Glycated Hemoglobin A/analysis ; Humans ; Hypoglycemic Agents/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use
    Chemical Substances Blood Glucose ; Glucagon-Like Peptide-1 Receptor ; Glycated Hemoglobin A ; Hypoglycemic Agents ; Sodium-Glucose Transporter 2 Inhibitors
    Language English
    Publishing date 2022-06-28
    Publishing country England
    Document type Journal Article
    ZDB-ID 2001535-5
    ISSN 1744-7666 ; 1465-6566
    ISSN (online) 1744-7666
    ISSN 1465-6566
    DOI 10.1080/14656566.2022.2089021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Formation of polycyclic aromatic hydrocarbons and regulated emissions from biodiesel and n-butanol blends containing water

    Yilmaz, Nadir / Davis, Stephen M.

    Journal of hazardous materials. 2022 Sept. 05, v. 437

    2022  

    Abstract: To increase the use of biofuels in diesel engines and reduce harmful emissions emitted from diesel fuel, biodiesel and higher alcohols are fuel sources at the forefront of research. The aim of this study is to understand the effect of water-containing n- ... ...

    Abstract To increase the use of biofuels in diesel engines and reduce harmful emissions emitted from diesel fuel, biodiesel and higher alcohols are fuel sources at the forefront of research. The aim of this study is to understand the effect of water-containing n-butanol-biodiesel blends on regulated emissions, emphasizing nitrogen oxides (NOₓ) and polycyclic aromatic hydrocarbons (PAHs), which are harmful for the environment and engine durability. 10% n-butanol (B90Bu10) and 10% n-butanol-1% water (B89Bu10W1) were blended with 89% waste-oil biodiesel and tested in a diesel engine at four engine loads at a constant engine speed. PAH samples were analyzed using gas chromatography-mass spectrometry (GC-MS). Results showed B100, B90Bu10 and B89Bu10W1 blends increased break specific fuel consumption (BSFC), exhaust gas temperatures (EGT), carbon monoxide (CO) and hydrocarbon (HC) emissions. However, NOₓ emissions significantly decreased using butanol and butanol-water blends. Compared to diesel, biodiesel and blended fuels significantly reduced total PAHs and PAH toxicity up to 75.0%. However, B89Bu10W1 increased total PAH and PAH toxicity by 35.7%. Overall, the biodiesel-butanol blend, which emits less carcinogenic pollutants and low-cyclic PAHs than water-containing fuel, was found to reduce the risk of wetstacking in diesel engines operating under low loads.
    Keywords biodiesel ; butanol ; carbon monoxide ; carcinogenicity ; diesel engines ; diesel fuel ; durability ; energy use and consumption ; gas chromatography-mass spectrometry ; nitrogen ; risk reduction
    Language English
    Dates of publication 2022-0905
    Publishing place Elsevier B.V.
    Document type Article
    ZDB-ID 1491302-1
    ISSN 1873-3336 ; 0304-3894
    ISSN (online) 1873-3336
    ISSN 0304-3894
    DOI 10.1016/j.jhazmat.2022.129360
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  9. Book: Centres of plant diversity / 3

    Davis, Stephen D.

    a guide and strategy for their conservation

    1997  

    Institution World Wide Fund for Nature
    Author's details publ. by the World Wide Fund for Nature (WWF) ... Ed. by S. D. Davis
    Collection Centres of plant diversity
    Language English
    Size XIV, 562 S. : Ill., graph. Darst., Kt.
    Publisher IUCN Publ. Unit
    Publishing place Cambridge
    Publishing country Great Britain
    Document type Book
    HBZ-ID HT007175458
    ISBN 2-8317-0199-6 ; 978-2-8317-0199-8
    Database Catalogue ZB MED Nutrition, Environment, Agriculture

    More links

    Kategorien

  10. Article ; Online: Type 1 diabetes: key drug targets and how they could influence future therapeutics.

    Kim, Yoon Kook / Munir, Kashif M / Davis, Stephen N

    Expert opinion on therapeutic targets

    2023  Volume 27, Issue 1, Page(s) 31–40

    Abstract: Introduction: Despite significant strides made in the management of T1DM, standard management is still insulin analog therapy. Some non-insulin therapies traditionally reserved for the treatment of T2DM have been explored in caring for patients with ... ...

    Abstract Introduction: Despite significant strides made in the management of T1DM, standard management is still insulin analog therapy. Some non-insulin therapies traditionally reserved for the treatment of T2DM have been explored in caring for patients with T1DM, and pancreas transplant is an option for few. However, T1DM remains a challenging disease to manage, encouraging development of novel pharmacologic agents.
    Areas covered: We retrieved PubMed, Cochrane Library, Scopus, Google Scholar, and ClinicalTrials.gov records to identify studies and articles focused on new pharmacologic advances to treat T1DM.
    Expert opinion: Recent research has focused on new targets of pharmacologic treatment of T1DM. Beta-cell preservation through immunomodulation or inhibiting inflammation hopes to delay or halt the progression of the disease. Beta cell regeneration through islet cell transplant or modification in transcription pathways aim to reverse the disease effects. Multiple other new targets such as glucagon antagonism and glucokinase activation are also in development as a potential adjunctive therapy. These new therapeutic targets offer the hope of reducing the daily burden of diabetes management with eventual insulin discontinuation for many individuals with T1DM.
    MeSH term(s) Humans ; Diabetes Mellitus, Type 1/drug therapy ; Insulin ; Insulin-Secreting Cells
    Chemical Substances Insulin
    Language English
    Publishing date 2023-02-13
    Publishing country England
    Document type Journal Article
    ZDB-ID 2055208-7
    ISSN 1744-7631 ; 1472-8222
    ISSN (online) 1744-7631
    ISSN 1472-8222
    DOI 10.1080/14728222.2023.2177150
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top